How Big Could BSX Stock’s Next Fall Be?
Boston Scientific (BSX) stock has lost more than half its value over the past 12 months, while the S&P 500 returned 18.0%. A subsequent setback occurred in September, when the company said a cyberattack would likely keep it from meeting its guidance. If the wider market turns now, how big could the next fall be, and how long would you wait? The answer depends on how well Boston Scientific is equipped to absorb a broader downturn today.
What Changed At Boston Scientific In 2026?
Boston Scientific’s growth slowed, and management cut its outlook. Quarterly revenue growth has slowed three times in a row. It fell from 20% three quarters earlier to 7.5% in the second quarter of 2026. On its July earnings call, management cut its 2026 revenue growth outlook to 5% to 6% on an organic basis.
Management said the cut was concentrated in two areas. The U.S. market for WATCHMAN, a device used for stroke prevention in atrial fibrillation, slowed sharply and unexpectedly. In electrophysiology, rivals took more U.S. market share than the company had expected. Management will not give a precise 2027 outlook until January. The company aims for 2027 to improve on its guidance for the second half of 2026.
Then a cyberattack disrupted manufacturing and order shipments. On September 8, the company said it would likely miss its guidance. The stock fell. Over the past month, the shares lost 8.8% while the S&P 500 gained 1.0%.
The business is slower, but it is not weaker on every count. Operating margin, the share of sales left after running costs, is 21%, up from 16.6% three years ago. Debt equals 17.8% of the company’s market value, below the S&P 500’s 21%. A market shock would meet a slower but still profitable company. The next question is how Boston Scientific stock has held up when the whole market fell.
Sell-Offs Hit Boston Scientific Slightly Harder Than The Index
In market shocks since 2007, Boston Scientific stock has fallen a little more than the S&P 500. Its average fall was 17.6%, against 15.8% for the index. The deepest was 54%, in the 2008-2009 Global Financial Crisis, when the S&P 500 fell 53%. Credit and liquidity crises have hurt the stock most, with falls averaging 26%. Its deepest slide of all came over a longer stretch. The shares lost 89% from a 2004 peak to a 2012 low.
The wait to recover was usually short. From the low, the median time back to the pre-shock high was 1.7 months. The stock made back all 14 of its falls. The slowest was the Summer 2007 Credit Crunch, when the climb back took 89.9 months. The 2008-2009 fall is the one worth sizing against your own money.
What Would Another Deep Fall Cost You?
The cost depends on how much of your portfolio Boston Scientific makes up. Say the stock is a tenth of your portfolio and everything else holds steady. A repeat of the 2008-2009 fall, starting from today’s price, would then cut the whole portfolio by 5.4%. If it is a fifth, the cut would be 10.8%. After that crisis, the stock needed 73.6 months from its low to regain its old high.
Boston Scientific’s slowing growth is the one fact that could make a repeat harder to sit through. The January outlook will show whether that slowdown is ending. An outlook that improves on the guidance for the second half of 2026 would point to a business picking up speed again. An outlook that does not improve would mean any market shock lands on a business that is still losing speed.
How To Act On BSX?
